Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Data: The total trading volume of 6 Hong Kong virtual asset ETFs today is approximately 315 million Hong Kong dollars

Data: The total trading volume of 6 Hong Kong virtual asset ETFs today is approximately 315 million Hong Kong dollars

Bitget2024/12/05 09:03

Hong Kong stock market data shows that as of the close, the total turnover of 6 Hong Kong virtual asset ETFs today was about HKD 315 million. Among them:

The turnover of Huaxia Bitcoin ETF (3042.HK) was HKD 246 million;

The turnover of Huaxia Ethereum ETF (3046.HK) was HKD 18.86 million;

The turnover of Jiashi Bitcoin ETF (3439.HK) was HKD 21.42 million;

The turnover of Jiashi Ethereum ETF (3179.HK) was HKD 1.61 million;

The turnover of Bosera HashKey Bitcoin ETF (3008.HK) was HKD 20.55 million;

The turnover of Bosera HashKey Ethereum ETF (3009.HK) was HKD 6.7 million.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46